Target intelligence / Profile preview

Dendritic cell activation via paracrine cytokine signaling

Molecular classification
Other (biological process; not a single receptor/enzyme)
01

Overview

Dendritic cell activation via paracrine cytokine signaling refers to the process by which DCs receive activation and maturation cues from cytokines secreted by neighboring cells (e.g., infected/stressed cells, innate immune cells), in addition to pathogen-sensing signals such as TLR agonists. At the molecular level, DC activation and maturation involve engagement of pattern-recognition receptors (notably TLRs) and cytokine receptors, which converge on key pathways including MAPK, NF-κB, and IRF, leading to upregulation of costimulatory molecules (CD40, CD80, CD86), enhanced antigen presentation (MHC), DC survival signals, and secretion of cytokines such as IL-12p70, IFN-α/β, and IL-10 that shape T cell polarization.[1][2][4] NF-κB signaling is closely linked with DC maturation, while ERK signaling contributes to survival during activation; these facets can be experimentally separable during LPS-induced activation.[1] The activation state and timing of maturation profoundly influence downstream T cell responses; for example, shorter ex vivo maturation intervals can enhance subsequent IL-12p70 production and T cell priming, informing DC vaccine design.[2] Functionally, activated DCs drive antigen-specific CD4+ and CD8+ T cell responses via antigen presentation and costimulatory and cytokine cues, impacting immunity against infections and tumors as well as autoimmune pathogenesis.[3][4][5]

Other names
DC activation by cytokinesparacrine cytokine-driven dendritic cell maturationcytokine-mediated DC activation
02

Mechanism of action

Costimulation blockade (inhibiting CD28–B7 or LFA-3–CD2 to reduce DC-driven T cell activation); TLR pathway agonism to promote DC maturation and cytokine production via MAPK, NF-κB, and IRFs; Modulation of JAK/STAT signaling in cytokine pathways influencing DC activation state (conceptual link within cytokine signaling to DCs)

03

Biological functions

Immune response (activation and polarization of T cells)Signal transduction (cytokine and TLR-driven pathways in DCs)Cell survival and maturation (NF-κB- and ERK-linked aspects during activation)
04

Disease associations

Cancer (DC activation state influences antitumor CD8+ T cell responses and DC-based vaccines)Autoimmune disease (altered DC–T cell activation contributes to pathogenesis)Infection (danger signals and cytokines drive DC activation for host defense)
05

Safety considerations

Overactivation may contribute to autoimmunity and immunopathology due to excessive T cell primingInsufficient activation may impair antitumor or anti-infective immunityUse of strong TLR agonists can cause systemic inflammation; timing/intensity of maturation affects DC function and potential exhaustion
06

Interacting drugs

CTLA-4–Ig (abatacept; blocks CD28–B7 costimulation, indirectly modulates DC–T cell activation)

3 more in the full profile.

07

Biomarkers

DC maturation/activation markers: increased CD40, CD80, CD86, MHC expression on DCsCytokine outputs from DCs: IL-12p70 (type 1–polarizing), IFN-α/β, IL-10; IL-12p70 is especially used to gauge type 1–polarizing capacityT cell functional readouts downstream of DC activation: IFN-γ production; antigen-specific CD8+ T cell induction

Beyond the preview

Go deeper on Dendritic cell activation via paracrine cytokine signaling.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dendritic cell activation via paracrine cytokine signaling.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call